Shantharam Harish
Insider CIK 1976391 · CBAY Chief Financial Officer · ALXO Chief Financial Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ALXO ALX ONCOLOGY HOLDINGS INC | A Award deriv | 2026-01-26 | 2026-01-28 | 303,000 | — | $0 | 303,000 | SEC↗ |
| ALXO ALX ONCOLOGY HOLDINGS INC | A Award deriv | 2025-10-14 | 2025-10-16 | 198,750 | — | $0 | 198,750 | SEC↗ |
| ALXO ALX ONCOLOGY HOLDINGS INC | P Buy | 2025-08-18 | 2025-08-20 | 75,000 | $0.78 | $58.5K | 75,000 | SEC↗ |
| ALXO ALX ONCOLOGY HOLDINGS INC | A Award deriv | 2025-04-11 | 2025-04-15 | 125,000 | — | $0 | 125,000 | SEC↗ |
| ALXO ALX ONCOLOGY HOLDINGS INC | A Award deriv | 2025-01-21 | 2025-01-23 | 600,000 | — | $0 | 600,000 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | D To issuer deriv | 2024-03-22 | 2024-03-22 | 74,750 | — | $0 | 0 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | D To issuer deriv | 2024-03-22 | 2024-03-22 | 360,000 | — | $0 | 0 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | D To issuer | 2024-03-22 | 2024-03-22 | 20,125 | — | $0 | 0 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | A Award deriv | 2024-01-24 | 2024-01-26 | 74,750 | — | $0 | 74,750 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | A Award | 2024-01-24 | 2024-01-26 | 20,125 | — | $0 | 20,125 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | A Award deriv | 2023-05-22 | 2023-05-22 | 360,000 | — | $0 | 360,000 | SEC↗ |